Sabra Health Care REIT, Inc. has entered into a new equity distribution agreement with a consortium of financial institutions, including major players such as Barclays Capital Inc., BMO Capital Markets Corp., and Morgan Stanley & Co. LLC. This agreement, established on August 5, 2025, allows for the sale of shares of the company's common stock, with proceeds intended for repaying debts, funding future investments, and general corporate purposes. The sales will be managed by the consortium, with an aggregate compensation for agents potentially reaching up to $11.25 million. The company also terminated a prior distribution agreement from February 2023 that allowed for up to $500 million in stock sales.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。